Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
AstraZeneca
Harvard Business School
McKinsey
Express Scripts

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: RUXOLITINIB PHOSPHATE


Email this page to a colleague

« Back to Dashboard

RUXOLITINIB PHOSPHATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Incyte Corp OPZELURA ruxolitinib phosphate CREAM;TOPICAL 215309 NDA Incyte Corporation 50881-007-04 1 TUBE in 1 CARTON (50881-007-04) > 5 g in 1 TUBE 2021-09-21
Incyte Corp OPZELURA ruxolitinib phosphate CREAM;TOPICAL 215309 NDA Incyte Corporation 50881-007-05 1 TUBE in 1 CARTON (50881-007-05) > 60 g in 1 TUBE 2021-09-21
Incyte Corp JAKAFI ruxolitinib phosphate TABLET;ORAL 202192 NDA Incyte Corporation 50881-005-60 60 TABLET in 1 BOTTLE, PLASTIC (50881-005-60) 2011-11-16
Incyte Corp JAKAFI ruxolitinib phosphate TABLET;ORAL 202192 NDA Incyte Corporation 50881-010-01 28 TABLET in 1 BOTTLE, PLASTIC (50881-010-01) 2011-11-16
Incyte Corp JAKAFI ruxolitinib phosphate TABLET;ORAL 202192 NDA Incyte Corporation 50881-010-60 60 TABLET in 1 BOTTLE, PLASTIC (50881-010-60) 2011-11-16
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Baxter
McKesson
McKinsey
Dow